ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$4.73
arrow_downward
-1.25%(-0.060) 1D
$4.73
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 25, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.80
High
$4.90
Low
$4.72
Mkt. cap
196.76M
Avg. vol.
222.44K
Volume
177.85K
P/E ratio
1.15
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.20
Shares outstanding
41.60M
No. of employees
13
Open
$4.80
High
$4.90
Low
$4.72
Mkt. cap
196.76M
Avg. vol.
222.44K
Volume
177.85K
P/E ratio
1.15
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.20
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
Stock Titan
·
15 hours ago
40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months.
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.